The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin - PubMed (original) (raw)
The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin
V Marin et al. J Immunol. 2001.
Abstract
Thrombin is a procoagulant and proinflammatory molecule in vivo. In vitro, thrombin has been shown to induce endothelial activation, notably IL-8 secretion and adhesion molecule expression. In this study, we showed that thrombin may induce a new cascade leading from acute to chronic inflammation. Thrombin was able to induce the production of both IL-6 and monocyte chemotactic protein-1 (MCP-1) by HUVEC independently of IL-1alphabeta and TNF-alpha. Addition of physiological concentrations of exogenous soluble IL-6Ralpha (sIL-6Ralpha) to thrombin-activated HUVEC was sufficient to increase the amounts of MCP-1 produced, but not those of IL-8. These effects could be blocked by anti-IL-6 or anti-sIL-6Ralpha blocking mAb, demonstrating the existence of an autocrine loop of MCP-1 secretion, involving the IL-6/IL-6Ralpha/gp130 complex on HUVEC. In addition, we identified IL-8-activated neutrophils as a potential source of sIL-6Ralpha because IL-8 induced IL-6Ralpha shedding from the neutrophil membranes and increased in parallel sIL-6Ralpha concentrations in neutrophil supernatants. Furthermore, addition of neutrophils to thrombin-activated HUVEC significantly increased MCP-1 secretion, which could be decreased by blocking IL-6. Thus, thrombin-activated endothelium may induce a cascade of events characterized by IL-8 secretion, neutrophil local infiltration, and the release of IL-6Ralpha from neutrophil membranes. sIL-6Ralpha may then complex with IL-6 and increase the amount of MCP-1 produced by thrombin-activated endothelium, favoring monocyte infiltration, and the transformation of acute into chronic inflammation.
Similar articles
- Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils.
Luu NT, Rainger GE, Nash GB. Luu NT, et al. J Immunol. 2000 Jun 1;164(11):5961-9. doi: 10.4049/jimmunol.164.11.5961. J Immunol. 2000. PMID: 10820279 - Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration.
Drake WT, Lopes NN, Fenton JW 2nd, Issekutz AC. Drake WT, et al. Lab Invest. 1992 Nov;67(5):617-27. Lab Invest. 1992. PMID: 1434539 - Interleukin-8: An evolving chemokine.
Matsushima K, Yang D, Oppenheim JJ. Matsushima K, et al. Cytokine. 2022 May;153:155828. doi: 10.1016/j.cyto.2022.155828. Epub 2022 Mar 2. Cytokine. 2022. PMID: 35247648 Review. - Interleukin-6 and chronic inflammation.
Gabay C. Gabay C. Arthritis Res Ther. 2006;8 Suppl 2(Suppl 2):S3. doi: 10.1186/ar1917. Epub 2006 Jul 28. Arthritis Res Ther. 2006. PMID: 16899107 Free PMC article. Review.
Cited by
- The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy.
Yeo ECF, Brown MP, Gargett T, Ebert LM. Yeo ECF, et al. Cells. 2021 Mar 9;10(3):607. doi: 10.3390/cells10030607. Cells. 2021. PMID: 33803414 Free PMC article. Review. - Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis.
Lockwood CJ, Murk WK, Kayisli UA, Buchwalder LF, Huang SJ, Arcuri F, Li M, Gopinath A, Schatz F. Lockwood CJ, et al. Am J Pathol. 2010 Oct;177(4):1755-64. doi: 10.2353/ajpath.2010.090781. Epub 2010 Aug 19. Am J Pathol. 2010. PMID: 20724602 Free PMC article. - Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.
Booth AJ, Csencsits-Smith K, Wood SC, Lu G, Lipson KE, Bishop DK. Booth AJ, et al. Am J Transplant. 2010 Feb;10(2):220-30. doi: 10.1111/j.1600-6143.2009.02826.x. Epub 2009 Sep 25. Am J Transplant. 2010. PMID: 19788504 Free PMC article. - Serum IL8 is not associated with cardiovascular events but with all-cause mortality.
Moreno Velásquez I, Gajulapuri A, Leander K, Berglund A, de Faire U, Gigante B. Moreno Velásquez I, et al. BMC Cardiovasc Disord. 2019 Feb 4;19(1):34. doi: 10.1186/s12872-019-1014-6. BMC Cardiovasc Disord. 2019. PMID: 30717657 Free PMC article. - Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain.
Wang XM, Hamza M, Wu TX, Dionne RA. Wang XM, et al. Pain. 2009 Apr;142(3):275-283. doi: 10.1016/j.pain.2009.02.001. Epub 2009 Feb 23. Pain. 2009. PMID: 19233564 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous